Publikationen von H. E. Künzel

Steiger, A.; Künzel, H. E.; Uhr, M.; Ackl, N.; Hatzinger, M.; Held, K.; Holsboer-Trachsler, E.; Ising, M.; Kaschka, W.; Kasper, S. et al.; Konstantinidis, A.; Sonntag, A.: Trimipramine is equivalent to combined treatment with amitriptyline and haloperidol in patients with delusional depression. Pharmacopsychiatry 38 (5), S. 279 - 279 (2005)

Ising, M.; Künzel, H. E.; Binder, E. B.; Nickel, T.; Modell, S.; Holsboer, F.: The combined dexamethasone/CRH test as a potential surrogate marker in depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry 29 (6), S. 1085 - 1093 (2005)

Künzel, H. E.; Ising, M.; Zobel, A. W.; Nickel, T.; Ackl, N.; Sonntag, A.; Holsboer, F.; Uhr, M.: Treatment with a CRH-1-receptor antagonist (R121919) does not affect weight or plasma leptin concentration in patients with major depression. Journal of Psychiatric Research 39 (2), S. 173 - 177 (2005)

Pfennig, A.; Künzel, H. E.; Kern, N.; Ising, M.; Majer, M.; Fuchs, B.; Ernst, G.; Holsboer, F.; Binder, E. B.: Hypothalamus-pituitary-adrenal system regulation and suicidal behavior in depression. Biological Psychiatry 57 (4), S. 336 - 342 (2005)

Himmerich, H.; Fulda, S.; Künzel, H. E.; Pfennig, A.; Dzaja, A.; Cummings, D. E.; Pollmächer, T.: Ghrelin plasma levels during psychopharmacological treatment. Neuropsychobiology 52, S. 11 - 16 (2005)

Kuenzel, H. E.; Steiger, A.; Held, K.; Antonijevic, I. A.; Frieboes, R.-M.; Murck, H.: Changes in sleep electroencephalogram and nocturnal hormone secretion after administration of the antidyskinetic agent sarizotan in healthy young male volunteers. Psychopharmacology 180, S. 327 - 332 (2005)

Künzel, H. E.; Schuld, A.; Pollmächer, T.: Sleepwalking associated with reboxetine in a young female patient with major depression - A case report. Pharmacopsychiatry 37 (6), S. 307 - 308 (2004)

Kuenzel, H. E.; Murck, H.; Held, K.; Ziegenbein, M.; Steiger, A.: Reboxetine induces similar sleep-EEG changes like SSRI's in patients with depression. Pharmacopsychiatry 37 (5), S. 193 - 195 (2004)

Held, K.; Künzel, H.; Ising, M.; Schmid, D. A.; Zobel, A.; Murck, H.; Holsboer, F.; Steiger, A.: Treatment with the CRH₁-receptor-antagonist R121919 improves sleep-EEG in patients with depression. Journal of Psychiatric Research 38 (2), S. 129 - 136 (2004)

Binder, E. B.; Salyakina, D.; Lichtner, P.; Wochnik, G. M.; Ising, M.; Pütz, B.; Papiol, S.; Seaman, S.; Lucae, S.; Kohli, M. et al.; Nickel, T.; Künzel, H.; Fuchs, B.; Majer, M.; Pfennig, A.; Kern, N.; Brunner, J.; Modell, S.; Baghai, T.; Deiml, T.; Zill, P.; Bondy, B.; Rupprecht, R.; Messer, T.; Köhnlein, O.; Dabitz, H.; Brückl, T.; Müller, N.; Pfister, H.; Lieb, R.; Mueller, J. C.; Löhmussaar, E.; Strom, T. M.; Bettecken, T.; Meitinger, T.; Uhr, M.; Rein, T.; Holsboer, F.; Müller-Myhsok, B.: Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nature Genetics 36, S. 1319 - 1325 (2004)

Majer, M.; Ising, M.; Künzel, H.; Binder, E. B.; Holsboer, F.; Modell, S.; Zihl, J.: Impaired divided attention predicts delayed response and risk to relapse in subjects with depressive disorders. Psychological Medicine 34, S. 1453 - 1463 (2004)

Murck, H.; Held, K.; Ziegenbein, M.; Künzel, H.; Holsboer, F.; Steiger, A.: Intravenous administration of the neuropeptide galanin has fast antidepressant efficacy and affects the sleep EEG. Psychoneuroendocrinology 29, S. 1205 - 1211 (2004)

Ziegenbein, M.; Held, K.; Kuenzel, H. E.; Murck, H.; Antonijevic, I. A.; Steiger, A.: The Somatostatin Analogue Octreotide Impairs Sleep and Decreases EEG Sigma Power in Young Male Subjects. Neuropsychopharmacology 29 (1), S. 146 - 151 (2004)

Künzel, H. E.; Binder, E. B.; Nickel, T.; Ising, M.; Fuchs, B.; Majer, M.; Pfennig, A.; Ernst, G.; Kern, N.; Schmid, D. A. et al.; Uhr, M.; Holsboer, F.; Modell, S.: Pharmacological and nonpharmacological factors influencing hypothalamic-pituitary-adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex-CRH test. Neuropsychopharmacology 28 (12), S. 2169 - 2178 (2003)

Künzel, H. E.; Zobel, A. W.; Nickel, T.; Ackl, N.; Uhr, M.; Sonntag, A.; Ising, M.; Holsboer, F.: Treatment of depression with the CRH-1-receptor antagonist R121919: endocrine changes and side effects. Journal of Psychiatric Research 37 (6), S. 525 - 533 (2003)

Brunner, J.; Ising, M.; Binder, E. B.; Künzel, H. E.; Nickel, T.; Pfennig, A.; Kern, N.; Fuchs, B.; Majer, M.; Holsboer, F. et al.; Modell, S.: Prediction of response to antidepressant monotherapy. Pharmacopsychiatry 36 (5), S. 216 - 216 (2003)

Ising, M.; Binder, E.; Brunner, J.; Fuchs, B.; Kern, N.; Künzel, H. E.; Majer, M.; Nickel, T.; Pfennig, A.; Modell, S. et al.; Holsboer, F.: Subsyndromal AMDP scales to distinguish pathogenetically homogenous subgroups of affective disorders. Pharmacopsychiatry 36 (5), S. 237 - 237 (2003)

Kern, N.; Binder, E. B.; Künzel, H. E.; Pfennig, A.; Fuchs, B.; Ising, M.; Erhardt, A.; Lucae, S.; Müller-Myhsok, B.; Modell, S. et al.; Keck, M. E.; Holsboer, F.: Is there a genetic continuum between anxiety and depression? Pharmacopsychiatry 36 (5), S. 239 - 239 (2003)

Pfennig, A.; Kuenzel, H. E.; Kern, N.; Fuchs, B.; Brunner, J.; Ising, M.; Modell, S.; Müller-Myhsok, B.; Binder, E. B.; Holsboer, F.: HPA axis dysregulation and suicidal behavior in depression - Differentiation of a genetically distinct subgroup? Pharmacopsychiatry 36 (5), S. 252 - 253 (2003)

Murck, H.; Held, K.; Ziegenbein, M.; Künzel, H.; Holsboer, F.; Steiger, A.: The neuropeptide galanin increases rem latency and alleviates depressed mood in patients with depression. Biological Psychiatry 53 (8 Suppl. Suppl. S), S. 131S - 131S (2003)